1 |
商庆新, 曹谊林, 张涤生. 生物工程领域的崭新前沿-组织工程[J]. 现代康复, 2001, 5(12): 7-9, 15.
|
2 |
KUMAR D, ANAND T, KUES W A. Clinical potential of human-induced pluripotent stem cells: perspectives of induced pluripotent stem cells[J]. Cell Biol Toxicol, 2017, 33(2): 99-112.
|
3 |
GALDERISI U, GIORDANO A. The gap between the physiological and therapeutic roles of mesenchymal stem cells[J]. Med Res Rev, 2014, 34(5): 1100-1126.
|
4 |
DING D C, CHANG Y H, SHYU W C, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy[J]. Cell Transplant, 2015, 24(3): 339-347.
|
5 |
LEE D K, SONG S U. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications[J]. Cell Immunol, 2018, 326: 68-76.
|
6 |
FURUTA T, MIYAKI S, ISHITOBI H, et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model[J]. Stem Cells Transl Med, 2016, 5(12): 1620-1630.
|
7 |
RUIZ M, COSENZA S, MAUMUS M, et al. Therapeutic application of mesenchymal stem cells in osteoarthritis[J]. Expert Opin Biol Ther, 2016, 16(1): 33-42.
|
8 |
ARJMAND B, ABEDI M, ARABI M, et al. Regenerative medicine for the treatment of ischemic heart disease; status and future perspectives[J]. Front Cell Dev Biol, 2021, 9: 704903.
|
9 |
GADKARI R, ZHAO L M, TEKLEMARIAM T,et al. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy[J]. Regen Med, 2014, 9(4): 453-465.
|
10 |
DAMDIMOPOULOU P, RODIN S, STENFELT S, et al. Human embryonic stem cells[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 31: 2-12.
|
11 |
ZHANG L F, WANG Y B, ZHANG Y, et al. Intermediate standstill clones trapped in the reprogramming of human fibroblasts to induced pluripotent stem cells[J]. Cell Reprogram,2020,22(2): 99-105.
|
12 |
JIANG B, YAN L, WANG X Y, et al. Concise review: mesenchymal stem cells derived from human pluripotent cells, an unlimited and quality-controllable source for therapeutic applications[J]. Stem Cells, 2019, 37(5): 572-581.
|
13 |
BARBERI T, WILLIS L M, SOCCI N D, et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells[J]. PLoS Med, 2005, 2(6): e161.
|
14 |
冯年花. 人胚胎干细胞源性间充质干细胞的研究进展[J]. 中国细胞生物学学报, 2015, 37(3): 409-415.
|
15 |
XU C H, JIANG J J, SOTTILE V, et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth[J]. Stem Cells, 2004, 22(6): 972-980.
|
16 |
SHEYN D, BEN-DAVID S, SHAPIRO G, et al. Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects[J]. Stem Cells Transl Med, 2016, 5(11): 1447-1460.
|
17 |
OLIVIER E N, RYBICKI A C, BOUHASSIRA E E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells[J]. Stem Cells, 2006, 24(8): 1914-1922.
|
18 |
GRUENLOH W, KAMBAL A, SONDERGAARD C, et al. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells[J]. Tissue Eng Part A, 2011, 17(11/12): 1517-1525.
|
19 |
KARLSSON C, EMANUELSSON K, WESSBERG F,et al. Human embryonic stem cell-derived mesenchymal progenitors: potential in regenerative medicine[J]. Stem Cell Res, 2009, 3(1): 39-50.
|
20 |
LIAN Q Z, LYE E, SUAN YEO K, et al. Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs[J].Stem Cells,2007,25(2): 425-436.
|
21 |
LIAN Q Z, ZHANG Y L, ZHANG J Q, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice[J]. Circulation, 2010, 121(9): 1113-1123.
|
22 |
YAN L, JIANG B, LI E Q, et al. Scalable generation of mesenchymal stem cells from human embryonic stem cells in 3D[J]. Int J Biol Sci, 2018, 14(10): 1196-1210.
|
23 |
CARTER K, LEE H J, NA K S, et al. Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo [J]. Acta Biomater, 2019, 99: 247-257.
|
24 |
BETTIOL E, SARTIANI L, CHICHA L, et al. Fetal bovine serum enables cardiac differentiation of human embryonic stem cells[J]. Differentiation, 2007, 75(8): 669-681.
|
25 |
LIN Y S, CHEN G K. Embryoid body formation from human pluripotent stem cells in chemically defined E8 media[J]. StemBook, 2014: StemBook, HarvardStemCellInstitute, 1June2014.
|
26 |
LI F, NIYIBIZI C. Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo [J]. BMC Cell Biol, 2012, 13: 35.
|
27 |
BRUSCHI M, SAHU N, SINGLA M, et al. A quick and efficient method for the generation of immunomodulatory mesenchymal stromal cell from human induced pluripotent stem cell[J]. Tissue Eng Part A, 2022, 28(9/10): 433-446.
|
28 |
ZHANG L S, WEI Y M, CHI Y, et al. Two-step generation of mesenchymal stem/stromal cells from human pluripotent stem cells with reinforced efficacy upon osteoarthritis rabbits by HA hydrogel[J]. Cell Biosci, 2021, 11(1): 6.
|
29 |
CHEN Y S, PELEKANOS R A, ELLIS R L, et al. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells[J]. Stem Cells Transl Med, 2012, 1(2): 83-95.
|
30 |
LIU Y X, GOLDBERG A J, DENNIS J E, et al. One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating[J]. PLoS One, 2012, 7(3): e33225.
|
31 |
LIU T M, YILDIRIM E D, LI P, et al. Ascorbate and iron are required for the specification and long-term self-renewal of human skeletal mesenchymal stromal cells[J]. Stem Cell Reports, 2020, 14(2): 210-225.
|
32 |
ARPORNMAEKLONG P, BROWN S E, WANG Z, et al. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells[J]. Stem Cells Dev, 2009, 18(7): 955-968.
|
33 |
WAGNER W, WEIN F, SECKINGER A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood[J]. Exp Hematol, 2005, 33(11):1402-1416.
|
34 |
石伦刚, 唐郑雅, 陆峻泓, 等. 人胚胎干细胞向类间充质干细胞的诱导分化及鉴定[J]. 上海交通大学学报(医学版), 2009, 29(3): 307-311.
|
35 |
MOORE J P, SAKKAL S, BULLEN M L, et al. A flow cytometric method for the analysis of macrophages in the vascular wall[J]. J Immunol Methods, 2013, 396(1/2): 33-43.
|
36 |
NASU A, IKEYA M, YAMAMOTO T, et al. Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin[J]. PLoS One, 2013, 8(1): e53771.
|
37 |
DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J].Cytotherapy,2006,8(4): 315-317.
|
38 |
CHOUDHERY M S, MAHMOOD R, HARRIS D T, et al. Minimum criteria for defining induced mesenchymal stem cells[J]. Cell Biol Int, 2022, 46(6): 986-989.
|
39 |
CHENG P P, LIU X C, MA P F, et al. iPSC-MSCs combined with low-dose rapamycin induced islet allograft tolerance through suppressing Th1 and enhancing regulatory T-cell differentiation[J]. Stem Cells Dev, 2015, 24(15): 1793-1804.
|
40 |
YU Y, WANG D P, LI H, et al. Mesenchymal stem cells derived from induced pluripotent stem cells play a key role in immunomodulation during cardiopulmonary resuscitation[J]. Brain Res, 2019, 1720: 146293.
|
41 |
DAVID S, KRONER A. Repertoire of microglial and macrophage responses after spinal cord injury[J]. Nat Rev Neurosci, 2011, 12(7): 388-399.
|
42 |
CHUNG M J, PARK S, SON J Y, et al. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use[J]. Cell Cycle, 2019, 18(21): 2954-2971.
|
43 |
QIN Y, CHAN A M, CHANG Y L, et al. Human embryonic stem cell-derived mesenchymal stromal cells decrease the development of severe experimental autoimmune uveitis in B10.RⅢ mice[J]. Ocul Immunol Inflamm, 2018, 26(8): 1228-1236.
|
44 |
YANG H S, FENG R, FU Q L, et al. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models[J]. Cell Death Dis, 2019, 10(10): 718.
|
45 |
TANG M H, CHEN W C, LIU J, et al. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration[J]. Tissue Eng Part A, 2014, 20(7/8): 1295-1305.
|
46 |
LIU J, CHEN W C, ZHAO Z H, et al. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering[J]. Biomaterials, 2013, 34(32): 7862-7872.
|
47 |
TAKEBE T, ZHANG R R, KOIKE H, et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant[J]. Nat Protoc, 2014, 9(2): 396-409.
|
48 |
QI X, NG K T, LIAN Q Z, et al. Glutathione peroxidase 3 delivered by hiPSC-MSCs ameliorated hepatic IR injury via inhibition of hepatic senescence[J]. Theranostics, 2018, 8(1): 212-222.
|
49 |
JIANG D, XIONG G Y, FENG H, et al. Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex Ⅰ defect-induced degeneration[J]. Theranostics, 2019, 9(8): 2395-2410.
|
50 |
GUO S Y, ZHANG Y S, ZHANG Y M, et al. Multiple intravenous injections of valproic acid-induced mesenchymal stem cell from human-induced pluripotent stem cells improved cardiac function in an acute myocardial infarction rat model[J]. Biomed Res Int, 2020, 2020: 2863501.
|
51 |
YOON S Y, YOON J A, PARK M, et al. Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice[J]. Stem Cell Res Ther, 2020, 11(1): 255.
|